[A Retrospective Study on the Efficacy and Safety of Idarubicin Combined with High-Dose Cytarabine Consolidation in Patients with Acute Myeloid Leukemia over 60 Years of Age in First Remission].
Zhongguo Shi Yan Xue Ye Xue Za Zhi
; 31(3): 671-676, 2023 Jun.
Article
in Zh
| MEDLINE
| ID: mdl-37356925
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Idarubicin
/
Leukemia, Myeloid, Acute
Type of study:
Etiology_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
Zh
Year:
2023
Type:
Article